D-0652-2020 Class II Terminated

Recalled by Asclemed USA Inc. Dba Enovachem Pharmaceuticals — Torrance, CA

FDA drug recall D-0652-2020 was initiated by Asclemed USA Inc. Dba Enovachem Pharmaceuticals on Dec 9, 2019 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results. The recall status is terminated (terminated Aug 9, 2023). Affected quantity: 56.4 gm.

Recall details

Product Type
Drugs
Report Date
Jan 15, 2020
Initiation Date
Dec 9, 2019
Termination Date
Aug 9, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
56.4 gm

Product description

Estriol, USP, (Micronized), 0.24 g, Distributed by Enovachem Pharmaceuticals, Torrance CA; NCD #76420-049-38

Reason for recall

Failed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.

Distribution pattern

Product was distributed to 6 physician's offices within the state of California.

Code information

Lot Code/Exp. Date: 11191804, 12281802, 01211902, 01281901, 02071903, 02221902, 03111903, 03251902, 04011905, 04091903, 04221907, 05211902, 06071902, 06241903, 07111903, 07301902, 08271902, 09061904, 09161902, EXP 12/31/2020; 09161901, 10091905, 10221902, 10311901, EXP 5/31/2021; 11211902, 10311902, EXP 8/31/2021

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0652-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0652-2020. Report a data issue: hello@regdatalab.com.